Kevin Morningstar brings 40 years of hands-on medical device experience in quality, regulatory, and clinical affairs to his venture investing role at Rockies Venture Fund, which is uncommon among VCs who typically come from finance backgrounds. He co-founded and successfully sold a medical device company to Stryker and continues working as a regulatory consultant, giving him direct FDA filing experience that keeps him connected to the day-to-day realities of getting complex devices to market.

• Focuses heavily on hands on startup education and accelerator programs. A major portion of the timeline revolves around organizing pitch practices, demo days, and intensive workshops through the Rockies Venture Club. For example, specific mentions of a six day intensive program highlight a focus on teaching founders fundamental metrics and concepts like customer acquisition cost, total addressable market, and how thorough due diligence results in better investor returns.
• Acts as an enthusiastic champion for early stage founders across a wide variety of industries. There is a strong habit of publicly celebrating portfolio milestones, graduating cohorts, and pitch events to help elevate the profiles of these startups. For instance, public praise is frequently given to specific teams like Silvernest, online mortgage startup Neat Capital, and a medical venture focused on advancing sepsis treatments.
• Demonstrates a clear interest in global innovation and cross border angel investing networks. Beyond local events in Denver, there is active engagement with the broader international startup ecosystem. An example of this is traveling to attend the European Business Angel Network conference in Spain, as well as mentoring international founders, such as a university team from Japan participating in a local program to disrupt the roofing tile industry.